These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 5511931)
1. [Clinical and biological effectiveness of citiolone and importance of its contribution in hepatic therapeutics]. Duché G Therapeutique; 1970 Dec; 46(10):1037-41. PubMed ID: 5511931 [No Abstract] [Full Text] [Related]
2. [Clinical study of citiolone, cyto-membranous hepatic protector]. Varay A; Castel A; Bloch J Therapeutique; 1970 Dec; 46(10):993-5. PubMed ID: 5511936 [No Abstract] [Full Text] [Related]
3. [Trial of LL 650 in various hepatic diseases]. Savoye B; Dietsch R; Chapuy M; Girard M J Med Lyon; 1972 May; 53(228):675-6 passim. PubMed ID: 5084113 [No Abstract] [Full Text] [Related]
4. [Clinico-statistical study of the therapeutic activity of coenzyme A in various hepatopathies]. Ruberti A; Tobaldin G; Montanari MG; Castellani P Clin Ter; 1971 May; 57(4):309-42. PubMed ID: 5110947 [No Abstract] [Full Text] [Related]
5. [Clinical trial of coenzyme A in hepatopathies]. Magaraci G Minerva Med; 1976 Feb; 67(8):512-8. PubMed ID: 943732 [TBL] [Abstract][Full Text] [Related]
6. [Clinical study on the treatment of liver disease with glucocorticoids]. Oda T; Suzuki H; Naito C; Yamanada M; Oka H Saishin Igaku; 1969 Oct; 24(10):2119-29. PubMed ID: 5349229 [No Abstract] [Full Text] [Related]
7. [Evaluation of the effectiveness of citiolone in hepatology; clinical and biological aspects]. Alary R; Dietsch R; Savoye B; Girard M J Med Lyon; 1971 Dec; 52(218):1631-7. PubMed ID: 5137693 [No Abstract] [Full Text] [Related]
13. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions]. Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451 [No Abstract] [Full Text] [Related]
14. [Experiences with ornithine-aspartate in liver diseases]. Aschke J Med Welt; 1969 Mar; 12():657-62. PubMed ID: 5767441 [No Abstract] [Full Text] [Related]
15. [Enzymatic therapy in hepatology with ornithine carbamol transferase]. Monges H; Hancy A; Codinach N Mars Med; 1971; 108(12):881-5. PubMed ID: 5145506 [No Abstract] [Full Text] [Related]
16. Treatment of liver disease with corticosteroids. Lesesne HR; Fallon HJ Med Clin North Am; 1973 Sep; 57(5):1191-201. PubMed ID: 4593197 [No Abstract] [Full Text] [Related]
17. [Prednisolone therapy of patients with chronic hepatitis and cirrhosis of the liver]. Vasil'eva LN Klin Med (Mosk); 1966 May; 44(5):42-8. PubMed ID: 5990929 [No Abstract] [Full Text] [Related]
18. [Further clinical experiences with ornithine aspartate in liver diseases]. Wotzka R; Weber D Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593 [No Abstract] [Full Text] [Related]
19. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation]. Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498 [No Abstract] [Full Text] [Related]
20. [The effect of furosemide on the liver function]. Pickert H; Müller K; Henning H Ther Ggw; 1966 Feb; 105(2):250-4. PubMed ID: 5915868 [No Abstract] [Full Text] [Related] [Next] [New Search]